Renovascular hypertension: Is there still a role for stent revascularization

Current Opinion in Nephrology and Hypertension

Volumn 22, Issue 5, 2013, Pages 525-530

  Textor, Stephen C ^a  

^a MAYO CLINIC   (United States)

Author keywords

hypertension; inflammation; mesenchymal stem cells; renal artery stenosis; stent; transforming growth factor b

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA;

ANTIHYPERTENSIVE THERAPY; ARTERIAL STENT; BLOOD PRESSURE REGULATION; CELL THERAPY; DETERIORATION; ESSENTIAL HYPERTENSION; EXPERIMENTAL STUDY; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; LONG TERM CARE; LUNG EDEMA; MAGNETIC RESONANCE ANGIOGRAPHY; MESENCHYMAL STEM CELL; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; QT PROLONGATION; RENAL REPLACEMENT THERAPY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; REPERFUSION INJURY; REVASCULARIZATION; REVIEW;

EID: 84882402566     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e328363ffe0     Document Type: Review

References (36)

1. Textor SC. Issues in renovascular disease and ischemic nephropathy: beyond ASTRAL. Curr Opin Nephrol Hyper tens 2011; 20:139-145.
2. Foy A, Ruggiero NJ, Filippone EJ. Revascularization in renal artery stenosis. Cardiol Rev 2012; 20:189-193.
3. Escobar GA, Campbell DN. Randomized trials in angioplasty and stenting of the renal artery: tabular review of the literature and critical analysis of their results. Ann Vasc Surg 2012; 26:434-442.
4. Kumbhani DJ, Bavry AA, Harvey JE, et al. Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta-analysis of randomized controlled trials. Am Heart J 2011; 161:622-630.
5. van den Berg DT, Postma CT, van der Wilt GJ, Riksen NP. The efficacy of renal angioplasty in patients with renal artery stenosis and flash oedema or congestive heart failure: a systematic review. Eu J Heart Fail 2012; 14:773-781.
6. White CJ. The need for randomized trials to prove the safety and efficacy of parachutes, bullet-proof vests, and percutaneous renal intervention. Mayo Clinic Proc 2011; 86:603-605.
7. Modrall JG, Rosero EE, Timaran CH, et al. Assessing outcomes to determine whether symptoms related to hypertension justify renal artery stenting. J Vasc Surg 2012; 55:413-419.
8. Mazza A, Rigatelli G, Piva M, et al. In high risk hypertensive subjects with incidental and unilateral renal artery stenosis, percutaneous revascularization with stent improves blood pressure control but not the glomerular filtration rate. Minerva Cardioangiol 2011; 59:533-542.
9. Kindo M, Gerelli S, Billaud P, Mazzucotelli JP. Flash pulmonary edema in an orthotopic heart transplant recipient. Interact Cardiovasc Thorac Surg 2011; 12:323-325.
10. Rossi GP, Seccia TM, Miotto D, et al. The medical and endovascular treatment of atherosclerotic renal artery stenosis (METRAS) study: rationale and study design. J Hum Hypertens 2012; 26:507-516.
11. Bourantas CV, Loh HP, Lukaschuk EI, et al. Renal artery stenosis: an innocent bystander or an independent predictor of worse outcome in patients with chronic heart failure A magnetic resonance imaging study. Eur J Heart Fail 2012; 14:764-772.
12. Mousa AY, Campbell JE, Stone PA, et al. Short and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period. J Vasc Surg 2012; 55:421-427.
13. Rooke TW, Hirsch AT, Misra S, et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease. J Am Coll Cardiol 2011; 58:2020-2045.
14. Chrysochou C, Foley RN, Young JF, et al. Dispelling the myth: the use of reninangiotensin blockade in atheromatous renovascular disease. Nephrol Dial Transplant 2012; 27:1403-1409.
15. Hackam DG, Duong-Hua ML, Mamdani M, et al. Angiotensin inhibition in renovascular disease: a population-based cohort study. Am Heart J 2008; 156:549-555.
16. Bramlage C, Cuneo A, Hartel D, et al. Renal artery stenosis: angioplasty or drug treatment. Deutsche Medizinische Wochenschrift 2011; 136:76-81.
17. Maule S, Bertello C, Rabbia F, et al. Ventricular repolarization before and after treatment in patients with secondary hypertension due to renal artery stenosis and primary aldosteronism. Hypertens Res 2011; 34:1078-1081.
18. Rognant N, Guebre-Egziabher F, Bachetta J, et al. Evolution of renal oxygen content measured by BOLD MRI downstream in a chronic renal artery stenosis. Nephrol Dial Transplant 2011; 26:1205-1210.
19. Gloviczki ML, Glockner JF, Lerman LO, et al. Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis. Hypertension 2010; 55:961-966.
20. Gloviczki ML, Glockner JF, Crane JA, et al. Blood oxygen level-dependent magnetic resonance imaging identifies cortical hypoxia in severe renovascular disease. Hypertension 2011; 58:1066-1072.
21. Gloviczki ML, Keddis MT, Garovic VD, et al. TGF expression and macrophage accumulation in atherosclerotic renal artery stenosis. Clin J Am Soc Nephrol 2013; 8:546-553.
22. Mann SJ, Sos TA. Misleading results of randomized trials: the example of renal artery stenting. J Clin Hypertens 2010; 12:1-2.
23. Messerli FH, Bangalore S, Makani H, et al. Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering Syndrome. Eur Heart J 2011; 32:2231-2237.
24. Chrysochou C, Schmitt M, Siddals K, et al. Reverse cardiac remodelling and renal functional improvement following bilateral renal artery stenting for flash pulmonary oedema. Nephrol Dial Transplant 2013; 28:479-483.
25. Madder RD, Hickman L, Crimmins GM, et al. Validity of estimated glomerular filtration rates for assessment of baseline and serial renal function in patients with atherosclerotic renal artery stenosis: implications for clinical trials of renal revascularization. Circ Cardiovasc Interv 2011; 4:219-225.
26. Textor SC. Atherosclerotic renal artery stenosis: flaws in estimated glomerular filtration rate and the problem of progressive kidney injury. Circ Cardiovasc Interv 2011; 4:213-215.
27. Eirin A, Gloviczki ML, Tang H, et al. Inflammatory and injury signals released from the poststenotic human kidney. Eur Heart J 2013; 34:540-548.
28. Warner GM, Cheng J, Knudsen BE, et al. Genetic deficiency of Smad3 protects the kidneys from atrophy and interstitial fibrosis in 2K1C hypertension. Am J Physiol Renal Physiol 2012; 302:F1455-F1464.
29. Kotliar C, Juncos L, Inserra F, et al. Local and systemic cellular immunity in early renal artery atherosclerosis. Clin J Am Soc Nephrol 2012; 7:224-230.
30. Eirin A, Zhu XY, Urbieta-Caceres VH, et al. Persistent kidney dysfunction in swine renal artery stenosis correlates with outer cortical microvascular remodeling. Am J Physiol Renal Physiol 2011; 300:F1394-F1401.
31. Cherr GS, Hansen KJ, Craven TE, et al. Surgical management of atherosclerotic renovascular disease. J Vasc Surg 2002; 35:236-245.
32. Textor SC, Misra S, Oderich G. Percutaneous revascularization for ischemic nephropathy: the past, present and future. Kidney Int 2013; 83:28-40.
33. Chade AR, Kelsen S. Reversal of renal dysfunction by targeted administration of VEGF into the stenotic kidney: a novel potential therapeutic approach. Am J Physiol Renal Physiol 2012; 302:F1342-F1350.
34. Chade AR, Zhu X, Lavi R, et al. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation 2009; 119:547-557.
35. Eirin A, Zhu XY, Krier JD, et al. Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cells 2012; 30:1030-1041.
36. Eirin A, Li Z, Xhang X, et al. A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis. Hypertension 2012; 60:1242-1249.